Prehospital aspirin for acute coronary syndrome in India: modelling the health loss from a national protocol gap
This study models the significant health burden caused by India's lack of a prehospital aspirin protocol for acute coronary syndrome, estimating that adopting a guideline recommending chewed, non-enteric-coated aspirin at first medical contact could avert nearly 24,000 deaths annually and is a highly cost-effective intervention.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Heart disease is a relentless force in India, claiming roughly 1.65 million lives every year. For decades, the medical world has known a simple, powerful way to stop a heart attack in its tracks: giving a patient aspirin the moment chest pain begins. This is not a new discovery but a well-established fact. When a heart muscle is starving for oxygen, a blood clot is usually the culprit. Aspirin acts as a chemical brake, stopping that clot from growing larger and blocking the flow of blood. The timing and the method matter immensely. To work quickly, the pill must be chewed to break it down faster, and it must be a plain version, not one coated to protect the stomach, because the coating slows the medicine down. International medical guidelines have long agreed that this simple act should happen before a patient even reaches a hospital, ideally while waiting for an ambulance.
Yet, India's official national plan for treating heart attacks has a silent gap. The current rules tell doctors to start aspirin only after a patient arrives at a primary health center or a hospital. The instructions do not mention chewing the pill, nor do they specify the type of tablet to use, even though the market is flooded with coated versions that work slower. This paper asks a stark question: what is the cost of this silence? The researchers did not just look at the rules; they built a detailed model to calculate the lives lost and the years of life shortened because this simple, pre-hospital step is missing from the national protocol. They wanted to know how many people could be saved if the country simply updated its instructions to match what the rest of the world has known for decades.
The study begins by challenging a common assumption. Many people might think that if a protocol is missing, it means patients are not getting aspirin at all. However, data from Indian hospitals shows that once a patient with a heart attack arrives alive, nearly everyone receives anti-clotting medication. The problem is not that they never get the drug; the problem is that they get it too late, or in a form that works too slowly. The researchers identified three specific ways a pre-hospital protocol would help. First, it would save the people who die before they can ever reach a hospital. For these individuals, a bystander or a dispatcher handing out a chewed tablet is the only chance they have. Second, it would ensure that everyone gets the plain, fast-acting version of the drug instead of the slower, coated kind. Third, it would speed up treatment for those who do make it to the hospital, giving their hearts a few extra minutes of protection.
To understand the scale of the loss, the team ran thousands of computer simulations using real Indian population data and medical outcomes. They compared the current situation against a scenario where the national protocol was updated to include pre-hospital aspirin. The results were striking. Under a realistic scenario where the new rules reached 55 percent of the population, the model suggests that nearly 24,000 deaths could be prevented every single year. These are not just statistics; they represent people who would live on. In terms of quality of life, this change would add over 216,000 years of healthy life annually. The cost of achieving this is incredibly low, estimated at just a few hundred dollars for every year of healthy life gained, making it one of the most efficient health interventions available. The model also showed that the benefits vastly outweighed the risks, with the positive outcome occurring in nearly every single simulation run.
The researchers also looked back in time to see what might have been lost over the last few decades. If India had adopted this simple protocol back in 1988, when the evidence first became clear, the model estimates that more than half a million deaths would have been averted by 2024. This historical perspective highlights that the gap in the protocol is not a minor oversight but a significant source of preventable suffering. The study emphasizes that the solution is not a complex new technology or a massive infrastructure overhaul. It is a change in words on a page, instructing that a chewed, plain aspirin be given immediately when chest pain starts.
The paper concludes that updating the national workflow to specify pre-hospital, chewed, non-coated aspirin is among the least expensive and most effective steps India's health system can take. It is a reminder that sometimes the most powerful tools in medicine are not the newest or the most expensive, but the ones that are already known and simply waiting to be used correctly. By closing this small gap in the national plan, the country could save tens of thousands of lives every year, turning a known solution into a reality for millions of people.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.